Katherine Eban

Stay informed with Katherine Eban’s coverage and analysis for Fortune.

  • What ails Big Pharma

    By

  • Ranbaxy’s empty promises

    By
  • Features

    Painful prescription

    By

  • Why the Supreme Court is wrong on generic drugs

    By

  • The latest to claim fraud at generic Lipitor maker Ranbaxy: Its owners

    By

  • Dirty medicine

    By

  • Maker of generic Lipitor pleads guilty to selling ‘adulterated drugs’

    By
  • blogging

    Are generics really the same as branded drugs?

    By
  • Features

    The Fast and Furious gun walking scandal

    By

  • The truth about the Fast and Furious scandal

    By